This new book summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone and venlafaxine in treating patients with MDD, dysthymia and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia or neurovegetative symptoms..
Acquista questo ebook e ricevine 1 in più GRATIS!
Formato PDF ● Pagine 475 ● ISBN 9781536115543 ● Editore Diane C Wimmer ● Casa editrice Nova Science Publishers ● Pubblicato 2017 ● Scaricabile 3 volte ● Moneta EUR ● ID 7216850 ● Protezione dalla copia Adobe DRM
Richiede un lettore di ebook compatibile con DRM